MDB Capital Holdings announces operational updates, including upcoming financings for two companies and expansion of its investment community.
Quiver AI Summary
MDB Capital Holdings, LLC (NASDAQ: MDBH) has announced an operational update for the third quarter of 2025, highlighting key offerings and developments. The company plans to close a $16.8 million private placement for Paulex Bio, a biopharmaceutical firm focusing on diabetes treatments, and a $20 million IPO for Buda Juice, which offers innovative cold-crafted juices. MDB is expanding its pipeline of early-stage companies and enhancing its public venture platform to launch new leaders in various industries, while also increasing its investor community through partnerships with angel groups and RIAs. CEO Christopher Marlett expressed optimism about the firm's ability to create a diversified portfolio with great potential. A related Zoom webinar will be held to discuss these updates and take questions from investors.
Potential Positives
- MDB Capital Holdings is poised to close a $16.8 million private placement offering for Paulex Bio, indicating strong investor interest in their biopharmaceutical initiative.
- The company is also set to launch a $20 million IPO for Buda Juice, reflecting growth and diversification in their investment portfolio.
- MDB has expanded its pipeline of early-stage companies, enhancing its position to identify and support potential market leaders in disruptive technologies.
- New relationships with angel group investors and expanded outreach to registered investment advisors could lead to a broader investor base and increased capital for future ventures.
Potential Negatives
- The company is relying on upcoming capital raises, such as the $16.8 million private placement and the $20 million IPO, which indicates that they may currently lack sufficient financial stability or revenue generation to support their operations without external funding.
- Forward-looking statements are heavily used in the release, which suggests a reliance on future expectations rather than current achievements; this may indicate uncertainty in performance and future prospects.
- There is an inherent risk mentioned regarding their forward-looking statements, which could lead to investor skepticism about the company’s ability to meet its projected goals and targets.
FAQ
What are the operational highlights for MDB Capital Holdings in Q3 2025?
MDB anticipates closing a $16.8 million private placement for Paulex Bio and a $20 million IPO for Buda Juice.
What is MDB Capital's focus as a public venture platform?
MDB aims to launch category-leading "Big Idea" companies by curating early-stage, disruptive technologies within various business sectors.
Who is leading the upcoming Zoom webinar for MDB's Q3 update?
Christopher Marlett, CEO and Co-Founder of MDB, will lead the webinar to discuss recent developments and milestones.
How is MDB expanding its investor community?
MDB welcomed TCA Venture Group and Keiretsu Forum MST investors, broadening relationships with RIAs to attract new investors.
Where can I access MDB's investor relations website?
You can access MDB's investor relations website at https://investors.mdb.com/ for webinar registration and updates.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$MDBH Insider Trading Activity
$MDBH insiders have traded $MDBH stock on the open market 24 times in the past 6 months. Of those trades, 24 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $MDBH stock by insiders over the last 6 months:
- CHRISTOPHER A MARLETT (Co-Founder) has made 24 purchases buying 24,950 shares for an estimated $90,885 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MDBH Hedge Fund Activity
We have seen 2 institutional investors add shares of $MDBH stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BEACON POINTE ADVISORS, LLC removed 25,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $84,087
- CITADEL ADVISORS LLC added 12,569 shares (+inf%) to their portfolio in Q3 2025, for an estimated $42,275
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 10,044 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $33,782
- RAYMOND JAMES FINANCIAL INC removed 6,100 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $20,517
- BLACKROCK, INC. removed 1,808 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,081
- UBS GROUP AG removed 943 shares (-1.6%) from their portfolio in Q3 2025, for an estimated $3,171
- EVERSOURCE WEALTH ADVISORS, LLC added 395 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,328
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Addison, TX, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended September 30, 2025, and subsequent developments.
Third Quarter 2025 and Subsequent Operational Highlights
- Anticipate closing two offerings shortly:
-
- This week: $16.8 million private placement offering for Paulex Bio, a biopharmaceutical company dedicated to sourcing, developing, and commercializing novel therapeutics for the treatment of diabetes.
- December 2025: $20 million IPO for Buda Juice, redefining the fresh juice category with UltraFresh™ cold-crafted juices.
- Expanded our pipeline of early-stage, disruptive companies capable of becoming leaders in new categories.
- Continued to improve the efficiency of our public venture platform to identify, curate and prepare to launch new category-leading companies with disruptive technologies.
- Welcomed TCA Venture Group and Keiretsu Forum MST angel group investors into latest offerings, further expanding MDB’s investor community.
- Broadened relationships with RIAs to reach new investors with large equity portfolios looking for new alternative investments strategies.
“We are making good progress in scaling public venture and creating a more efficient platform for being a leader in the asset class,” said Christopher Marlett, CEO and Co-Founder of MDB Capital Holdings. “With the pace picking up in our pipeline, we’re convinced more than ever that we can create a diversified portfolio of highly curated public venture opportunities with asymmetric upside potential for our community.”
Third Quarter 2025 Update Zoom Webinar at 4:30 p.m. ET Today
Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments, ongoing initiatives, and anticipated milestones, as well as host a question-and-answer session.
Investors can pre-register now for the Zoom webinar HERE . The live webinar will also be accessible on the day of the event through MDB’s investor relations website at https://investors.mdb.com/ .
About MDB Capital Holdings, LLC
Founded in 1997, MDB Capital focuses on launching "Big Ideas" through a unique approach to public venture capital. The firm emphasizes community-driven financings of early-stage leaders in significant business and technology categories via early public offerings, primarily on NASDAQ, as well as post-IPO offerings for qualifying companies. MDB Capital Holdings, LLC (NASDAQ: MDBH) and its subsidiaries—including MDB Capital, a venture-focused broker-dealer with the MDB Direct trading platform, and PatentVest, the first integrated IP strategy and law firm—operate under the MDB Capital brand. MDB Capital is a registered broker-dealer, Member FINRA/SIPC.
For more information, please visit www.mdb.com .
Forward-Looking Statements
This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.
Securities trading, account management, and investment banking services are offered by MDB Capital, a wholly owned subsidiary of MDB Capital Holdings, LLC (Nasdaq: MDBH) and a registered broker-dealer and member of FINRA and SIPC. Unless clearly stated, nothing herein shall be construed to be an offer to sell, nor a solicitation of an offer to buy, any financial product. For more information, please refer to MDB Capital’s Client Relationship Summary, or Form CRS, the uniform disclosure that provides succinct information about a firm’s services and responsibilities, fees and costs, and standards of conduct, at: https://www.mdb.com/disclosures/customer-relationship-summary/ .
Investor Relations Contact:
[email protected]
Media Contact:
[email protected]